Mary Ellen Wernette-Hammond

Title: Mary Ellen Wernette-Hammond: Innovator in IL8 Inhibitors

Introduction

Mary Ellen Wernette-Hammond is a notable inventor based in Leandro, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of IL8 inhibitors. With a total of 2 patents, her work has the potential to impact various therapeutic applications.

Latest Patents

Wernette-Hammond's latest patents focus on IL8 inhibitors. These inhibitors include antibodies that bind to IL8 receptors, interacting with the amino-terminal extracellular domain of the IL8 receptor. They compete with IL8 for receptor-binding, making them useful modulators of IL8 receptor-mediated biological activity. This innovative approach could lead to advancements in treating conditions related to IL8 activity.

Career Highlights

Throughout her career, Wernette-Hammond has worked with prominent organizations, including Chiron Corporation. Her expertise in biotechnology and patent development has established her as a key figure in her field.

Collaborations

Wernette-Hammond has collaborated with several professionals, including Patricia A Tekamp-Olson and Guy T Mullenbach. These collaborations have contributed to her innovative work and the advancement of her patents.

Conclusion

Mary Ellen Wernette-Hammond's contributions to the field of IL8 inhibitors highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing biotechnology and improving therapeutic options.